In-situ immune profile of polymorphic vs. macular Indian Post Kala-azar dermal leishmaniasis.

Autor:	Sengupta R; Dept. of Pharmacology, Institute of Post Graduate Medical Education and Research, Kolkata, 700020, India., Mukherjee S; Dept. of Pharmacology, Institute of Post Graduate Medical Education and Research, Kolkata, 700020, India., Moulik S; Dept. of Pharmacology, Institute of Post Graduate Medical Education and Research, Kolkata, 700020, India., Mitra S; Dept. of Pharmacology, Institute of Post Graduate Medical Education and Research, Kolkata, 700020, India., Chaudhuri SJ; Dept. of Microbiology, Govt. Medical College, Purulia, India., Das NK; Dept. of Dermatology, Bankura Sammilani Medical College, Bankura, 722102, India., Chatterjee U; Dept. of Pathology, Institute of Post Graduate Medical Education and Research, Kolkata, 700020, India. Electronic address: uttarac1@gmail.com., Chatterjee M; Dept. of Pharmacology, Institute of Post Graduate Medical Education and Research, Kolkata, 700020, India. Electronic address: ilatimc@gmail.com.
Jazyk:	angličtina
Zdroj:	International journal for parasitology. Drugs and drug resistance [Int J Parasitol Drugs Drug Resist] 2019 Dec; Vol. 11, pp. 166-176. Date of Electronic Publication: 2019 Aug 22.
DOI:	10.1016/j.ijpddr.2019.08.005
Abstrakt:	Post Kala-azar Dermal Leishmaniasis (PKDL), a sequel of apparently cured Visceral Leishmaniasis presents in South Asia with papulonodular (polymorphic) or hypomelanotic lesions (macular). Till date, the polymorphic variant was considered predominant, constituting 85-90%. However, following active-case surveillance, the proportion of macular PKDL has increased substantially to nearly 50%, necessitating an in-depth analysis of this variant. Accordingly, this study aimed to delineate the cellular infiltrate in macular vis-à-vis polymorphic PKDL. To study the overall histopathology, hematoxylin and eosin staining was performed on lesional sections and phenotyping by immunohistochemistry done in terms of dendritic cells (CD1a), macrophages (CD68), HLA-DR, T-cells (CD8, CD4), B-cells (CD20) and Ki67 along with assessment of the status of circulating homing markers CCL2, CCL7 and CXCL13. In polymorphic cases (n = 20), the cellular infiltration was substantial, whereas in macular lesions (n = 20) it was mild and patchy with relative sparing of the reticular dermis. Although parasite DNA was identified in both variants by ITS-1 PCR, the parasite load was significantly higher in the polymorphic variant and Leishman-Donovan bodies were notably minimally present in macular cases. Both variants demonstrated a decrease in CD1a + dendritic cells, HLA-DR expression and CD4 + T-cells. In macular cases, the proportion of CD68 + macrophages, CD8 + T-cells and CD20 + B-cells was 4.6 fold, 17.0 fold and 1.6 fold lower than polymorphic cases. The absence of Ki67 positivity and increased levels of chemoattractants suggested dermal homing of these cellular subsets. Taken together, as compared to the polymorphic variant, patients with macular PKDL demonstrated a lower parasite load along with a lesser degree of cellular infiltration, suggesting differences in host-pathogen interactions, which in turn can impact on their disease transmitting potential and responses to chemotherapy. (Copyright © 2019 The Authors. Published by Elsevier Ltd.. All rights reserved.)
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu